RE: Newsflow2 Mar 2022 10:08
@Suggins LOL, yes I've tried to do some forecasting for Phase 3 completion:
> 2koz production - I suspect will be Q3/4 to hit 2koz production, BUT is not the same as "steady state" 2koz production as Dec-21 1koz throughput demonstrated
> Kilimapesa LOM - based on current 670koz resource & 2koz/month or 24koz/annum steady state gives a very respectable 26+ year LOM rising to 40+ years as resource upgrades to 1Moz come through from 3km DD drill programme
> Kilimapesa Production - I'm assuming 24koz steady state production will be achieved in Q4 2022 given profile to date:
>> Q3 2021 @1.550oz
>> Q4 2021 @2.088oz
... and assuming forward profile Q1 @2.5koz +Q2 @3koz +Q3 @4koz +Q4 @6koz
> Kilimapesa AISC - this is tricky given low forecast cash cost of $860 will likely drop further as process plant capacity, efficiency and throughput rises especially once HL facility is onstream to deal with lower grade ROM ore. IMHO given infill drilling has already been paid/accounted for and decent LOM confirmed then circa $1,050/oz looks very achievable
GCAT is currently a strong gold growth stock with a small but rapidly growing production facility bolted on to fund organic growth from FCF so valuation is not straightforward, but a minimum £50m MCap at $1,900 POG looks very achievable or a 3x bump from current SP given low implied AISC plus shallow, high-grade exploration and pipeline growth if you sit on your hands for 6-10 months depending on speed of Phase 3 progress.
The real valuation 'Joker' is the 1Moz near-term development prospect at Nyakafuru which could add an initial 25koz to 50koz production inside 2 years. I also suspect a Phase 4 expansion at Kilimapesa will deliver better ROI taking Kili from 24koz to 50koz in 2022/23 timeframe.
If POG takes off from current levels to $2,200+ then FCF will explode and that valuation will come forward very fast as GCAT is heavily geared given Q3/4 2021 actuals and 2022 target production figures clearly show.
AIMHO ATB APR